FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response

In studies of electron and proton radiotherapy, ultrahigh dose rates of FLASH radiotherapy appear to produce fewer toxicities than standard dose rates while maintaining local tumor control. FLASH-proton radiotherapy (F-PRT) brings the spatial advantages of PRT to FLASH dose rates (>40 Gy/second),...

Descripción completa

Detalles Bibliográficos
Autores principales: Velalopoulou, Anastasia, Karagounis, Ilias V., Cramer, Gwendolyn M., Kim, Michele M., Skoufos, Giorgos, Goia, Denisa, Hagan, Sarah, Verginadis, Ioannis I., Shoniyozov, Khayrullo, Chiango, June, Cerullo, Michelle, Varner, Kelley, Yao, Lutian, Qin, Ling, Hatzigeorgiou, Artemis G., Minn, Andy J., Putt, Mary, Lanza, Matthew, Assenmacher, Charles-Antoine, Radaelli, Enrico, Huck, Jennifer, Diffenderfer, Eric, Dong, Lei, Metz, James, Koumenis, Constantinos, Cengel, Keith A., Maity, Amit, Busch, Theresa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2021
Materias:
Translational Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715480/
https://www.ncbi.nlm.nih.gov/pubmed/34321243
http://dx.doi.org/10.1158/0008-5472.CAN-21-1500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715480/
https://www.ncbi.nlm.nih.gov/pubmed/34321243
http://dx.doi.org/10.1158/0008-5472.CAN-21-1500

Ejemplares similares